125 related articles for article (PubMed ID: 6885547)
1. Selective tumor localization in experimental hepatoma by radiolabeled antiferritin antibody.
Rostock RA; Klein JL; Leichner P; Kopher KA; Order SE
Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1345-50. PubMed ID: 6885547
[TBL] [Abstract][Full Text] [Related]
2. Variables affecting the tumor localization of 131I-antiferritin in experimental hepatoma.
Rostock RA; Klein JL; Kopher KA; Order SE
Am J Clin Oncol; 1984 Feb; 7(1):9-18. PubMed ID: 6695855
[TBL] [Abstract][Full Text] [Related]
3. Distribution of and physiologic factors that affect 131I-antiferritin tumor localization in experimental hepatoma.
Rostock RA; Klein JL; Leichner PK; Order SE
Int J Radiat Oncol Biol Phys; 1984 Jul; 10(7):1135-41. PubMed ID: 6746354
[TBL] [Abstract][Full Text] [Related]
4. Ferritin concentration and 131I-antiferritin tumor localization in an experimental hepatoma.
Klein JL; Kopher KA; Rostock RA
Int J Radiat Oncol Biol Phys; 1986 Jan; 12(1):137-40. PubMed ID: 3943985
[TBL] [Abstract][Full Text] [Related]
5. The effect of iron dextran on ferritin content and 131I-antiferritin localization in experimental hepatomas.
Rostock RA; Kopher KA; Bauer TW; Klein JL
Cancer Drug Deliv; 1985; 2(1):3-9. PubMed ID: 3902193
[TBL] [Abstract][Full Text] [Related]
6. Factors that affect antiferritin localization in four rat hepatoma models.
Rostock RA; Kopher KA; Bauer TW; Klein JL
Cancer Drug Deliv; 1985; 2(2):139-45. PubMed ID: 3902194
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody.
Saiful Alam AF
Br J Cancer; 1991 Apr; 63(4):503-7. PubMed ID: 2021533
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry of 131I-labeled antiferritin in hepatoma: specific activities in the tumor and liver.
Leichner PK; Klein JL; Siegelman SS; Ettinger DS; Order SE
Cancer Treat Rep; 1983; 67(7-8):647-58. PubMed ID: 6307515
[TBL] [Abstract][Full Text] [Related]
9. Yttrium-90 and iodine-131 radioimmunoglobulin therapy of an experimental human hepatoma.
Klein JL; Nguyen TH; Laroque P; Kopher KA; Williams JR; Wessels BW; Dillehay LE; Frincke J; Order SE; Leichner PK
Cancer Res; 1989 Nov; 49(22):6383-9. PubMed ID: 2553255
[TBL] [Abstract][Full Text] [Related]
10. Dosimetry and treatment planning for 90Y-labeled antiferritin in hepatoma.
Leichner PK; Yang NC; Frenkel TL; Loudenslager DM; Hawkins WG; Klein JL; Order SE
Int J Radiat Oncol Biol Phys; 1988 May; 14(5):1033-42. PubMed ID: 2834309
[TBL] [Abstract][Full Text] [Related]
11. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
Order SE; Stillwagon GB; Klein JL; Leichner PK; Siegelman SS; Fishman EK; Ettinger DS; Haulk T; Kopher K; Finney K
J Clin Oncol; 1985 Dec; 3(12):1573-82. PubMed ID: 2415692
[TBL] [Abstract][Full Text] [Related]
12. Antiferritin IgG antibody for isotopic cancer therapy.
Order SE; Klein JL; Leichner PK
Oncology; 1981; 38(3):154-60. PubMed ID: 6259569
[TBL] [Abstract][Full Text] [Related]
13. Antiferritin antibodies in immunoscintigraphic detection of human tumor xenografts.
Koprivová H; Novák F; Poucková P; Dvorák P; Seblová J; Svihovcová P; Dusková J; Pospísil J; Dienstbier Z
Int J Biol Markers; 1988; 3(3):159-64. PubMed ID: 3230335
[TBL] [Abstract][Full Text] [Related]
14. The theoretical implications and experimental and clinical results of radiolabeled antiferritin.
Order SE
Acta Oncol; 1990; 29(6):689-94. PubMed ID: 2223137
[TBL] [Abstract][Full Text] [Related]
15. In vivo visualization of rat anaplastic carcinoma with 131I-antiferritin antibodies.
Lukac J; Kordić D; Matić-Piantanida D; Spaventi S
Int J Rad Appl Instrum B; 1987; 14(5):445-50. PubMed ID: 3117737
[No Abstract] [Full Text] [Related]
16. 90Yttrium antiferritin--a new therapeutic radiolabeled antibody.
Order SE; Klein JL; Leichner PK; Frincke J; Lollo C; Carlo DJ
Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):277-81. PubMed ID: 3005201
[TBL] [Abstract][Full Text] [Related]
17. [131I antiferritin in the treatment of hepatoma and Hodgkin's disease].
Cohen Y; Moroz H
Harefuah; 1986 Dec; 111(11):398-9. PubMed ID: 3028919
[No Abstract] [Full Text] [Related]
18. Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01.
Vriesendorp HM; Herpst JM; Germack MA; Klein JL; Leichner PK; Loudenslager DM; Order SE
J Clin Oncol; 1991 Jun; 9(6):918-28. PubMed ID: 2033428
[TBL] [Abstract][Full Text] [Related]
19. Radiation enhancement of radiolabelled antibody deposition in tumors.
Msirikale JS; Klein JL; Schroeder J; Order SE
Int J Radiat Oncol Biol Phys; 1987 Dec; 13(12):1839-44. PubMed ID: 3679921
[TBL] [Abstract][Full Text] [Related]
20. Immunoscintigraphy and distribution study of experimental tumours using 131I-labelled anti-fibrinogen antibodies.
Svihovcová P; Koprivová H; Glagolicová A; Novák F; Sůrová H; Dienstbier Z
Eur J Nucl Med; 1984; 9(10):478-81. PubMed ID: 6595116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
